Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CLPTNYSEAMERICAN:MYONASDAQ:NNOXNASDAQ:SMLR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLPTClearPoint Neuro$13.31-4.5%$12.71$5.11▼$19.22$372.53M0.93241,410 shs426,119 shsMYOMyomo$2.97-0.3%$3.92$2.76▼$7.17$89.84M1.68392,477 shs521,544 shsNNOXNano-X Imaging$5.52-0.2%$5.05$3.75▼$11.00$318.94M1.991.75 million shs862,815 shsSMLRSemler Scientific$33.99+3.1%$35.77$21.77▼$81.56$379.06M1.42505,760 shs1.12 million shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLPTClearPoint Neuro-4.45%+12.89%-6.14%+4.80%+136.83%MYOMyomo-0.34%+1.37%-7.19%-49.40%-14.90%NNOXNano-X Imaging-0.18%+5.54%+5.34%+1.47%-29.59%SMLRSemler Scientific+3.06%-4.50%-2.30%+3.63%+7.46%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCLPTClearPoint Neuro1.365 of 5 stars3.52.00.00.00.60.00.6MYOMyomo3.2595 of 5 stars3.53.00.00.04.02.50.6NNOXNano-X Imaging2.0452 of 5 stars3.53.00.00.02.30.00.6SMLRSemler Scientific2.8445 of 5 stars3.52.00.00.02.22.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLPTClearPoint Neuro 3.00Buy$25.0087.83% UpsideMYOMyomo 3.00Buy$9.63224.07% UpsideNNOXNano-X Imaging 3.00Buy$9.5072.10% UpsideSMLRSemler Scientific 3.00Buy$71.00108.88% UpsideCurrent Analyst Ratings BreakdownLatest MYO, CLPT, SMLR, and NNOX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/6/2025NNOXNano-X ImagingD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.006/5/2025MYOMyomoAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$11.00 ➝ $11.505/23/2025NNOXNano-X ImagingD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$15.00 ➝ $10.005/22/2025NNOXNano-X ImagingAlliance Global PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy5/8/2025MYOMyomoCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$11.00 ➝ $10.004/17/2025NNOXNano-X ImagingD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$15.00 ➝ $15.004/1/2025CLPTClearPoint NeuroStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$19.00 ➝ $25.004/1/2025NNOXNano-X ImagingCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$12.00 ➝ $9.003/31/2025NNOXNano-X ImagingD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$15.00 ➝ $15.003/17/2025MYOMyomoAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$9.00 ➝ $11.003/12/2025MYOMyomoHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$7.50 ➝ $9.50(Data available from 6/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLPTClearPoint Neuro$32.24M11.56N/AN/A$0.86 per share15.48MYOMyomo$19.24M4.67N/AN/A$0.34 per share8.74NNOXNano-X Imaging$11.55M27.63N/AN/A$3.55 per share1.55SMLRSemler Scientific$49.23M7.70$2.01 per share16.95$10.45 per share3.25Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLPTClearPoint Neuro-$22.09M-$0.76N/AN/AN/A-59.64%-62.10%-38.39%8/6/2025 (Estimated)MYOMyomo-$8.15M-$0.23N/AN/AN/A-33.22%-86.30%-52.72%8/5/2025 (Estimated)NNOXNano-X Imaging-$60.78M-$0.90N/AN/AN/A-465.38%-27.63%-24.72%8/19/2025 (Estimated)SMLRSemler Scientific$20.58M-$2.616.92∞N/A72.65%50.77%47.04%8/4/2025 (Estimated)Latest MYO, CLPT, SMLR, and NNOX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/22/2025Q1 2025NNOXNano-X Imaging-$0.23-$0.21+$0.02-$0.21$3.98 million$3.00 million5/13/2025Q1 2025CLPTClearPoint Neuro-$0.15-$0.22-$0.07-$0.22$8.21 million$8.49 million5/13/2025Q1 2025SMLRSemler ScientificN/A-$0.76N/A-$6.74N/A$8.84 million3/31/2025Q4 2024NNOXNano-X Imaging-$0.15-$0.23-$0.08-$0.23$3.80 million$3.00 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLPTClearPoint NeuroN/AN/AN/AN/AN/AMYOMyomoN/AN/AN/AN/AN/ANNOXNano-X ImagingN/AN/AN/AN/AN/ASMLRSemler ScientificN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLPTClearPoint NeuroN/A4.543.61MYOMyomoN/A2.101.62NNOXNano-X ImagingN/A4.644.56SMLRSemler ScientificN/A3.143.09Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLPTClearPoint Neuro30.08%MYOMyomo44.99%NNOXNano-X Imaging21.49%SMLRSemler Scientific49.37%Insider OwnershipCompanyInsider OwnershipCLPTClearPoint Neuro6.97%MYOMyomo4.54%NNOXNano-X Imaging7.74%SMLRSemler Scientific30.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLPTClearPoint Neuro11027.99 million25.90 millionOptionableMYOMyomo9030.25 million28.87 millionNot OptionableNNOXNano-X Imaging19057.78 million53.31 millionOptionableSMLRSemler Scientific12011.15 million6.47 millionNot OptionableMYO, CLPT, SMLR, and NNOX HeadlinesRecent News About These CompaniesSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. ...June 9 at 3:07 PM | gurufocus.comSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJune 9 at 3:00 PM | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLRJune 9 at 12:45 PM | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Encourages Semler Scientific, Inc. (SMLR) Shareholders to Inquire about Securities InvestigationJune 9 at 10:00 AM | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Is Investigating Semler Scientific, Inc. (SMLR) And Encourages Investors to ConnectJune 8 at 10:00 AM | accessnewswire.comSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You ...June 7 at 3:50 PM | bakersfield.comSemler Scientific Inc call volume above normal and directionally bullishJune 7 at 3:50 PM | msn.comROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLRJune 7 at 10:10 AM | markets.businessinsider.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLRJune 7 at 10:00 AM | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLRJune 6, 2025 | globenewswire.comBronstein, Gewirtz & Grossman, LLC Encourages Semler Scientific, Inc. (SMLR) Stockholders to Inquire about Securities InvestigationJune 6, 2025 | accessnewswire.comSemler Scientific, Inc. (SMLR) Faces Scrutiny from Edelson Lechtzin LLPJune 5, 2025 | insidermonkey.comRosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLRJune 5, 2025 | prnewswire.comBronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Semler Scientific, Inc. (SMLR) and Encourages Investors to Learn More About the InvestigationJune 5, 2025 | accessnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLRJune 5, 2025 | accessnewswire.comSemler Scientific (NASDAQ:SMLR) & CeriBell (NASDAQ:CBLL) Financial ReviewJune 5, 2025 | americanbankingnews.comINVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of Semler Scientific, Inc. (NASDAQ: SMLR) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the FirmJune 4, 2025 | prnewswire.comSemler Scientific Updates Bylaws for Governance EfficiencyJune 4, 2025 | tipranks.comSemler Scientific Adds 185 Bitcoins in $20M Deal, Reports 26.7% BTC Yield in 2025June 4, 2025 | crypto2community.comSemler Scientific Acquires 185 Bitcoin, Increasing Total Holdings to 4,449 BTCJune 4, 2025 | bitcoinmagazine.comNuveen Asset Management LLC Acquires 99,482 Shares of Semler Scientific, Inc. (NASDAQ:SMLR)May 31, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMYO, CLPT, SMLR, and NNOX Company DescriptionsClearPoint Neuro NASDAQ:CLPT$13.31 -0.62 (-4.45%) Closing price 06/9/2025 04:00 PM EasternExtended Trading$13.39 +0.08 (+0.59%) As of 06/9/2025 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.Myomo NYSEAMERICAN:MYO$2.97 -0.01 (-0.34%) Closing price 06/9/2025 04:10 PM EasternExtended Trading$2.97 0.00 (0.00%) As of 06/9/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.Nano-X Imaging NASDAQ:NNOX$5.52 -0.01 (-0.18%) Closing price 06/9/2025 04:00 PM EasternExtended Trading$5.50 -0.01 (-0.27%) As of 06/9/2025 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.Semler Scientific NASDAQ:SMLR$33.99 +1.01 (+3.06%) Closing price 06/9/2025 04:00 PM EasternExtended Trading$34.76 +0.77 (+2.25%) As of 06/9/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Tightly-Held Growth Stocks Set Up for Short Squeezes Palantir Stock Holds Support, Despite Political Backlash Science Applications International Is a Wicked Hot Buy in June Why Unity Software May Be the AI Breakout No One Saw Coming Tesla Stock Dips to Buy Zone—Robotaxi Catalyst Ahead? Is Lululemon’s 18% Selloff Overdone? Analysts Say Yes MarketBeat Week in Review – 06/02 - 06/06 This Banking Giant Just Got a $90 Price Target Upgrade Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
